AFM
CLRBZ

Anson Funds Management’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

Anson Funds Management’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-233,330
Closed -$518K – 118
2019
Q4 		$518K Buy
+233,330
New +$518K 0.6% 45